Skip to main content
. 2022 Sep 1;18(9):2167–2172. doi: 10.5664/jcsm.10068

Table 4.

Secondary analyses: other outcome results.

Variable Non-White (n = 55) White (n = 55) P*
Post-treatment AHI, events/h 14.1 ± 15.6 12.9 ± 13.54 .9
Median: 9.9 Median: 10.1
Change in ESS 3.6 ± 4.6 3.4 ± 5.4 .9
Response rate (Sher) 65.4% (36) 65.4% (36) 1

*Wilcoxon rank sum test at a significance level of .05. AHI = apnea-hypopnea index, ESS = Epworth Sleepiness Scale, Sher = criteria for treatment success defined as of 50% reduction in AHI and treatment AHI <20.